Home > Financial Ratios > CONCORD DRUGS

CONCORD DRUGS
Core EBITDA Margin

    Back to All Ratios
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 9.149.008.789.49

What is the latest Core EBITDA Margin ratio of CONCORD DRUGS ?

The latest Core EBITDA Margin ratio of CONCORD DRUGS is 9.14 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar20259.14
Mar20249.00
Mar20238.78
Mar20229.49

How is Core EBITDA Margin of CONCORD DRUGS Trending?

Years Core EBITDA Margin % Change
Mar2025 9.14
1.56
Mar2024 9
2.51
Mar2023 8.78
-7.48
Mar2022 9.49 -

Other Financial Ratios of CONCORD DRUGS


Compare Core EBITDA Margin ratio of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹99.0 Cr -5.7% 5.6% 9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,565.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 4.5% 1.8% -10% Stock Analytics


CONCORD DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-5.7%

5.6%

9.1%

SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses